A Study of Keluo Xin Capsule Compare to Placebo in Terms of Efficacy and Safety in Patients With Diabetic Retinopathy
Phase 2
- Conditions
- Moderately Severe to Severe NPDR
- Interventions
- Drug: Keluo Xin capsuleDrug: Placebo oral capsule
- First Posted Date
- 2017-08-23
- Last Posted Date
- 2017-08-24
- Lead Sponsor
- Chengdu Kanghong Pharmaceutical Co., Ltd.
- Target Recruit Count
- 198
- Registration Number
- NCT03258242
Β© Copyright 2025. All Rights Reserved by MedPath